Merck to Share Covid Pill Formula With Poor Countries
Merck, the American pharmaceutical company, has signed a royalty-free license waiver for their oral antiviral COVID drug molnupiravir. This will ...
Read moreMerck, the American pharmaceutical company, has signed a royalty-free license waiver for their oral antiviral COVID drug molnupiravir. This will ...
Read moreParaphrasing Tina Turner’s great song about love and secondhand emotions some would ask what does the UN General Assembly have ...
Read moreUpdate 14 June, 8:30 pm: Just out, the communiqué from the NATO meeting in Brussels attended by President Biden. At ...
Read moreThis is chapter two in Europe’s COVID Vaccine mess. The first chapter recently reported on here, tried to explain why ...
Read moreCOVID-19 has dominated 2020 with unimaginable harm to health, economies, livelihood, and political stability. In the last few months, there ...
Read moreImpakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2025 IMPAKTER. All rights reserved.